Sales improved sequentially in the fourth quarter of calendar year 2009 for major publicly traded analytical and life science instrument companies. Firms remained optimistic about improved economic conditions this year, with many forecasting a gradual improvement in sales as the year progresses. However, as many also noted, results will also benefit from favorable year-over-year comparisons. […]
Funding for many American Recovery and Reinvestment Act (ARRA) (see IBO 4/30/09, 6/15/09) programs has been disbursed for almost six months now, but much of the money for many instrument- and facilities-specific programs has only begun to be released in the past few months. Instrument companies have reported moderate spikes in 2009 sales due to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
